Becky Hollenberg

speaker

57 appearances 1 recordings 1 series first heard Jul 2026 last heard 13 Jul

Becky Hollenberg’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment

tHEORetically Speaking · From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap · 13 Jul 2026 podcast

Yeah.

So for example, if we're looking at a treatment discontinuation that we see in a moderate to severe immunology patient.

So if we look at claims alone, we might see that the patient discontinued therapy.

They had one fill, they didn't refill it, but we don't really understand the reason why.

And that's kind of all we're left with.

There's not really any layer there.

If we add on EMR data, we can understand based on lab values and the patient had an ER visit showing that their disease was worsening.

We can see that their discontinuation was linked to a flare.

And so then we can kind of rule out that that's not due to poor adherence or the patient didn't pick up the drug they actually had.

a real life outcome that led to that discontinuation.

Within the clinical notes, we can then look and see the progress note and the physician notice that the patient might have had an injection site reaction.

So we can understand that that switch was clinically warranted and had a reason behind it that we weren't seeing within the structured data.

And then with the payer access data, we can see maybe the physician notes that they're going to switch the patient to a new therapy

And then in the claims, we see that that therapy was denied.

And when we layer in the access data there, we understand that that was denied because the patient didn't have the proper step therapy allowing them for insurance to cover it.

So we can see how the access barrier leads to the patient not getting on the switch therapy.

So in some, you know, each level layer of evidence as we layer on different pieces of this disparate data source, we see how this patient interaction can be reframed from a lost patient to something that can actually be an access barrier that could be defended against and kind of utilized by teams to then have more effective engagement.

Showing 41–57 of 57 · page 3 of 3